Cyclin A Promotes S-Phase Entry via Interaction with the Replication Licensing Factor Mcm7

被引:35
|
作者
Chibazakura, Taku [1 ]
Kamachi, Kazuhiro [1 ]
Ohara, Mayu [1 ]
Tane, Shoji [1 ]
Yoshikawa, Hirofumi [1 ]
Roberts, James M. [2 ]
机构
[1] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan
[2] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA
关键词
CDK-DEPENDENT PHOSPHORYLATION; DNA-REPLICATION; RETINOBLASTOMA PROTEIN; HETEROHEXAMERIC COMPLEXES; MAMMALIAN FIBROBLASTS; CHROMOSOMAL DNA; KINASE-ACTIVITY; BUDDING YEAST; CELL-CYCLE; BINDING;
D O I
10.1128/MCB.00630-10
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin A is known to promote S-phase entry in mammals, but its critical targets in this process have not been defined. We derived a novel human cyclin A mutant (CycA-C1), which can activate cyclin-dependent kinase but cannot promote S-phase entry, and isolated replication licensing factor Mcm7 as a factor that interacts with the wild-type cyclin A but not with the mutant. We demonstrated that human cyclin A and Mcm7 interact in the chromatin fraction. To address the physiological significance of the cyclin A-Mcm7 interaction, we isolated an Mcm7 mutant (Mcm7-3) that is capable of association with CycA-C1 and found that it can also suppress the deficiency of CycA-C1 in promoting S-phase entry. Finally, RNA interference experiments showed that the CycA-C1 mutant is defective for the endogenous cyclin A function in S-phase entry and that this defect can be suppressed by the Mcm7-3 mutant. Our findings demonstrate that interaction with Mcm7 is essential for the function of cyclin A in promoting S-phase entry.
引用
收藏
页码:248 / 255
页数:8
相关论文
共 50 条
  • [1] Replication licensing and S-phase CDK
    Mimura, S
    Takisawa, H
    SEIKAGAKU, 1999, 71 (04): : 255 - 268
  • [2] MCM7,a replication licensing factor, interacts with the cell cycle regulator p27kip1
    Nallamshetty, S
    Boehm, M
    Yoshimoto, T
    Nabel, EG
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 693 - 693
  • [3] Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
    Juan Li
    Jie Liu
    Zheyong Liang
    Fang He
    Lu Yang
    Pingping Li
    Yina Jiang
    Bo Wang
    Can Zhou
    Yaochun Wang
    Yu Ren
    Jin Yang
    Jianmin Zhang
    Zhijun Luo
    Cyrus Vaziri
    Peijun Liu
    Cell Death & Disease, 2017, 8 : e2673 - e2673
  • [4] Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
    Liang, Zheyong
    Li, Wenjie
    Liu, Jie
    Li, Juan
    He, Fang
    Jiang, Yina
    Yang, Lu
    Li, Pingping
    Wang, Bo
    Wang, Yaochun
    Ren, Yu
    Yang, Jin
    Luo, Zhijun
    Vaziri, Cyrus
    Liu, Peijun
    SCIENTIFIC REPORTS, 2017, 7
  • [5] Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
    Li, Juan
    Liu, Jie
    Liang, Zheyong
    He, Fang
    Yang, Lu
    Li, Pingping
    Jiang, Yina
    Wang, Bo
    Zhou, Can
    Wang, Yaochun
    Ren, Yu
    Yang, Jin
    Zhang, Jianmin
    Luo, Zhijun
    Vaziri, Cyrus
    Liu, Peijun
    CELL DEATH & DISEASE, 2017, 8 : e2673 - e2673
  • [6] Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
    Zheyong Liang
    Wenjie Li
    Jie Liu
    Juan Li
    Fang He
    Yina Jiang
    Lu Yang
    Pingping Li
    Bo Wang
    Yaochun Wang
    Yu Ren
    Jin Yang
    Zhijun Luo
    Cyrus Vaziri
    Peijun Liu
    Scientific Reports, 7
  • [7] The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication
    Nallamshetty, S
    Crook, M
    Boehm, M
    Yoshimoto, T
    Olive, M
    Nabel, EG
    FEBS LETTERS, 2005, 579 (29): : 6529 - 6536
  • [8] Depletion of replication factor MCM7 is synthetically lethal to oncogenic KRAS expression
    Gastl, Bastian
    Klotz-Noack, Kathleen
    Klinger, Bertram
    Zuber, Johannes
    Bluethgen, Nils
    Schaefer, Reinhold
    Sers, Christine
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
  • [9] PRMT5 promotes colorectal cancer growth by interaction with MCM7
    Li, Xiangwei
    Wang, Xin
    Zhao, Jiahui
    Wang, Jian
    Wu, Jingjing
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (07) : 3537 - 3547
  • [10] OVEREXPRESSION OF HUMAN CYCLIN-A ADVANCES ENTRY INTO S-PHASE
    ROSENBERG, AR
    ZINDY, F
    LEDEIST, F
    MOULY, H
    METEZEAU, P
    BRECHOT, C
    LAMAS, E
    ONCOGENE, 1995, 10 (08) : 1501 - 1509